Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to… Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL
INITIALIZE TERMINAL
Select up to 5 assets to monitor in your personal Watchlist. This builds your core market profile.
GUEST MODE: Watchlist is temporary. Login or Register to sync permanently and unlock Top 1-5 Champions.
UNITED STATES
